ExMediKA

ExMediKA has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €275,693 and a net result of €94,786. Equity is growing by ~52.2% per year across the filed fiscal years. Its solvency ranks better than 72% of 4272 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).